Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Lactate production is important for activating hair growth stem cells.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The conclusion is that tissue structure is key for stem cell communication and maintaining healthy tissues.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

c-Kit is important for heart regeneration and cancer development.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Eclipta alba may improve memory and help treat Alzheimer's disease.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Certain Chinese herbs may help treat kidney fibrosis by targeting TGF-β.

Key genes influencing sheep hair follicle development were identified, aiding wool breeding and understanding human hair conditions.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Ruxolitinib treatment may cause eyelash growth.

The research found that the gene activity in mouse skin stem cells changes significantly as they age.